4.4 Article

Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: A retrospective two-center cohort study

期刊

PEDIATRIC BLOOD & CANCER
卷 60, 期 5, 页码 799-805

出版社

WILEY
DOI: 10.1002/pbc.24380

关键词

chemotherapy; fever definition; fever in neutropenia; infection; pediatric oncology

向作者/读者索取更多资源

Background The definition of fever, and thus fever and neutropenia (FN), varies between different pediatric oncology centers. Higher temperature limit should reduce FN rates, but may increase rates of FN with complications by delaying therapy. This study determined if different fever definitions are associated with different FN rates. Procedure Two pediatric oncology centers had used three fever definitions in 20042011: ear temperature 38.5 degrees C persisting 2hours (low definition); axillary temperature 38.5 degrees C 2hours or 39.0 degrees C once (middle); and ear temperature 39.0 degrees C once (high). Clinical information was retrospectively extracted from charts. FN rates were compared using mixed Poisson regression. Results In 521 pediatric patients with cancer, 783 FN were recorded during 6,009 months cumulative chemotherapy exposure time (501 years; rate, 0.13/month [95% CI, 0.120.14]), 124 of them with bacteremia (16%; 0.021/month [0.0170.025]). In univariate analysis, the high versus low fever definition was associated with a lower FN rate (0.10/month [0.080.11] vs. 0.15/month [0.130.16]; rate ratio, 0.66 [0.450.97]; P=0.036), the middle definition was intermediate (0.13/month [0.110.15]). This difference was not confirmed in multivariate analysis (rate ratio, 0.94 [0.671.33]; P=0.74). The high versus low definition was not associated with an increased rate of FN with bacteremia (multivariate rate ratio, 1.39 [0.533.62]; P=0.50). Conclusion A higher fever definition was not associated with a lower FN rate, nor with an increased rate of FN with bacteremia. These may be false negative findings due to methodological limitations. These questions, with their potential impact on health-related quality of life, and on costs, need to be assessed in prospective studies. Pediatr Blood Cancer 2013; 60: 799805. (c) 2012 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据